You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 January 2026 - UK biopharmaceutical company GSK plc (LSE/NYSE: GSK) on Tuesday announced a definitive agreement to acquire RAPT Therapeutics (NASDAQ:RAPT), a California-based clinical-stage biopharmaceutical company, in a transaction valued at app...
20 January 2026 - Chinese biotechnology company iRegene Therapeutics Co Ltd announced on Monday that its lead product, NouvNeu001, has received Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) f...
20 January 2026 - Alcami Corporation, a US-based contract development and manufacturing organisation (CDMO), announced on Monday that it has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina.This USD6.7m invest...
20 January 2026 - German biopharmaceutical company Boehringer Ingelheim announced on Monday that the US Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) Chewable Tablets and VETMEDIN Solution (pimobendan oral solution), for the d...
19 January 2026 - Precision oncology company Guardant Health Inc (Nasdaq: GH) announced on Monday that it has entered into a multi-year strategic collaboration with pharmaceutical firm Merck, known as MSD outside the United States and Canada, to supp...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe